{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/pruritus-vulvae/management/management/","result":{"pageContext":{"chapter":{"id":"39b5f2b6-2faf-5764-932b-10c3cfa35b9c","slug":"management","fullItemName":"Scenario: Management","depth":2,"htmlHeader":"<!-- begin field f13b5a2c-2d57-49dc-a630-0ef2c0a00487 --><h2>Scenario: Management of pruritus vulvae</h2><!-- end field f13b5a2c-2d57-49dc-a630-0ef2c0a00487 -->","summary":"Covers the management of pruritus vulvae both when an underlying cause has been established and when an underlying cause cannot be found.","htmlStringContent":"<!-- begin item d374a8fc-ba59-4ccf-8763-da0698afa1c6 --><!-- begin field a3133930-066f-4d16-9bc5-acbc0155e13b --><p>From birth onwards (Female).</p><!-- end field a3133930-066f-4d16-9bc5-acbc0155e13b --><!-- end item d374a8fc-ba59-4ccf-8763-da0698afa1c6 -->","topic":{"id":"ab775596-ee36-566c-b99e-f26281476587","topicId":"f736b71a-0394-4d1b-81d3-89f92387f7b5","topicName":"Pruritus vulvae","slug":"pruritus-vulvae","lastRevised":"Last revised in May 2017","chapters":[{"id":"e95d24eb-aeb8-50bb-ac51-8f64aea3c30a","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"8ce4dbd7-2246-5775-ae6e-04329c1190c1","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"982a2f05-e887-58b7-b162-572ce0d3ee9f","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"38dfa294-fe36-5eaf-801f-f85edcaf9b0c","slug":"changes","fullItemName":"Changes"},{"id":"3ad7e907-7bc6-5339-9fe3-a53a943a1d5b","slug":"update","fullItemName":"Update"}]},{"id":"cfeab3a1-33f8-5401-bf2d-554006509e44","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"f358fbd3-3112-597d-8318-782024ffb462","slug":"goals","fullItemName":"Goals"},{"id":"06d9f87d-ffb9-5c80-94cc-c14fabec72e4","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"00abbaa1-76de-5699-92e4-c7966d120fb9","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"8c5bcf9e-40a1-5ec5-bfb3-8b61c5e05271","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"9e5947c9-06ae-527b-b39d-99249cc183b7","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"acce3106-835f-51e5-8d2a-474eb1210f06","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"ede3d467-474d-5337-a3a8-69e962cdb78d","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"fed1d461-c450-5ad2-b137-ba2e7b3e25ba","slug":"definition","fullItemName":"Definition"},{"id":"69ac7b79-9272-52fb-b41a-85c62d368278","slug":"causes","fullItemName":"Causes"},{"id":"540240f7-7b5f-5dd8-9778-add2bad7a948","slug":"prevalence","fullItemName":"Prevalence"},{"id":"f32fb44d-4398-544d-8e12-40abce15c8ac","slug":"prognosis","fullItemName":"Prognosis"},{"id":"d3481fe5-fb32-5604-a01e-ef3831740641","slug":"complications","fullItemName":"Complications"}]},{"id":"ea7b6574-3e2d-5558-b3fc-e26e23ee9841","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"cb8a05d1-5735-53f1-9f3d-a8eeeaf04c43","slug":"assessment","fullItemName":"Assessment"},{"id":"d9fb23e4-f170-5e35-baf1-eb5e9eb3ef93","slug":"causes","fullItemName":"Causes"},{"id":"b2f116aa-c92b-555e-bf3d-4d48002ac082","slug":"investigations","fullItemName":"Investigations"}]},{"id":"33ec4dfa-a698-5c63-ba2b-63ff2bd4f94a","fullItemName":"Management","slug":"management","subChapters":[{"id":"39b5f2b6-2faf-5764-932b-10c3cfa35b9c","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"879b4dcf-9fd5-5785-ad0a-f78ce4711c69","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"40a71a96-802a-52ed-936a-8be2564e3966","slug":"topical-corticosteroids","fullItemName":"Topical corticosteroids"},{"id":"5a7e3fc5-3dcc-5ae7-b42c-cfd50c0b6427","slug":"hydroxyzine","fullItemName":"Hydroxyzine"}]},{"id":"e8fd8512-18b4-5a87-b393-c17a7aeea18c","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"22929cbe-97bb-51fd-848d-fb564e84e824","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"16e021f3-7a43-5db6-91c6-f2928df8f0d3","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"1e67be49-3ad9-5c49-afd7-3b4003a9e1ac","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"aa214653-3cef-5171-bc52-2abc1dca4efe","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"9f82fff6-ebda-5cfb-8995-424680c23073","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"3a44b88d-e6de-5027-a2a5-aab8d22fae10","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"2255e17a-9ac2-5004-9c32-22c36192790a","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"33ec4dfa-a698-5c63-ba2b-63ff2bd4f94a","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"1e6cf7de-5a7c-5478-82a4-01f758424878","slug":"known-cause","fullItemName":"Known cause","depth":3,"htmlHeader":"<!-- begin field 65c13551-4c2a-4926-91df-ff6db5392d1d --><h3>How should I manage pruritus vulvae with a known cause?</h3><!-- end field 65c13551-4c2a-4926-91df-ff6db5392d1d -->","summary":null,"htmlStringContent":"<!-- begin item e725f99e-f146-416c-b8c6-d2132796b0d5 --><!-- begin field e440e719-f128-446f-af7a-8f8242e58681 --><ul><li>A comprehensive discussion of the management of specific causes of pruritus vulvae is beyond the scope of this topic. A brief discussion follows, with links to other relevant CKS topics.</li><li>Most women who present with pruritus vulvae have an identifiable cause which can be managed, including:<ul><li><a class=\"topic-reference internal-reference\" href=\"/topics/pruritus-vulvae/management/management/#dermatological-conditions\">Dermatological conditions</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/pruritus-vulvae/management/management/#infections-infestations\">Infections and infestations</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/pruritus-vulvae/management/management/#possible-neoplasm\">Possible neoplasm</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/pruritus-vulvae/management/management/#hormonal-changes\">Hormonal changes</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/pruritus-vulvae/management/management/#gastrointestinal-disease-urinary-incontinence\">Gastrointestinal disease and urinary incontinence</a>.</li><li><a class=\"topic-reference internal-reference\" href=\"/topics/pruritus-vulvae/management/management/#systemic-causes\">Systemic causes</a>.</li></ul></li></ul><!-- end field e440e719-f128-446f-af7a-8f8242e58681 --><!-- end item e725f99e-f146-416c-b8c6-d2132796b0d5 -->","subChapters":[{"id":"cb19b60d-d9fa-5878-b615-93bb3db21742","slug":"dermatological-conditions","fullItemName":"Dermatological conditions","depth":4,"htmlHeader":"<!-- begin field 5e807718-79db-4c3b-ba76-0e38ea9611dc --><h4>How should I manage dermatological conditions?</h4><!-- end field 5e807718-79db-4c3b-ba76-0e38ea9611dc -->","summary":null,"htmlStringContent":"<!-- begin item 45b3bdf8-d24a-4ec6-b08b-aa91266e257b --><!-- begin field 71cf58ca-6edd-4f13-9c78-3388d3227bd2 --><ul><li><strong>Manage the underlying dermatological cause of pruritus vulvae in primary care where appropriate.</strong><ul><li><strong>Contact dermatitis</strong><ul><li>Identify and remove exposure to irritants (for example soaps and deodorants).</li><li>For mild itching, consider prescribing a mild potency topical corticosteroid ointment, such as hydrocortisone 1% for 7–10 days.</li><li>Stronger potency corticosteroids (such as betamethasone or clobetasol) may be considered if, symptoms are severe, if the skin is lichenified, or to break the itch-scratch-cycle. </li><li>Recommend an emollient as a soap substitute. </li><li>Treat co-existing infection with a combination corticosteroid/antifungal, or corticosteroid/antibacterial if required.</li><li>Consider referral to dermatology for skin patch testing if avoidance of irritants and topical corticosteroids have not improved the condition.</li><li>For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/dermatitis-contact/\">Dermatitis - contact</a>.</li></ul></li><li><strong>Seborrhoeic dermatitis</strong><ul><li>Ketoconazole shampoo can be used as body wash for seborrhoeic dermatitis.</li><li>For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/seborrhoeic-dermatitis/\">Seborrhoeic dermatitis</a>.</li></ul></li><li><strong>Psoriasis</strong><ul><li>For management information, see the section on <a class=\"topic-reference external-reference\" href=\"/topics/psoriasis/management/facial-flexural/genital-psoriasis/#topical-drug-treatment\">Treatment</a> in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/psoriasis/\">Psoriasis</a>.</li></ul></li><li><strong>Lichen simplex</strong><ul><li>Identify and avoid precipitating factors.</li><li>Consider prescribing a potent topical corticosteroid ointment (such as betamethasone), for 1–2 weeks to break the itch-scratch cycle and bring the condition under control.</li><li>Consider prescribing a mildly anxiolytic antihistamine (for example hydroxyzine) for use at night.</li><li>Recommend an emollient as a soap substitute.</li></ul></li><li><strong>Lichen sclerosus and lichen planus</strong><ul><li>Refer to secondary care to confirm the diagnosis.</li><li>Once the diagnosis is confirmed in secondary care, very potent corticosteroids are usually initiated by a specialist. Repeated, intermittent courses of topical steroids may be required for longer-term management.</li></ul></li></ul></li><li><strong>For more information on prescribing:</strong><ul><li><strong>Topical corticosteroids: </strong>see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/corticosteroids-topical-skin-nose-eyes/\">Corticosteroids - topical (skin), nose, and eyes</a>.</li><li><strong>Emollients: </strong>see the section on <a class=\"topic-reference external-reference\" href=\"/topics/eczema-atopic/prescribing-information/emollients/\">Emollients</a> in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/eczema-atopic/\">Eczema - atopic</a>.</li></ul></li></ul><!-- end field 71cf58ca-6edd-4f13-9c78-3388d3227bd2 --><!-- end item 45b3bdf8-d24a-4ec6-b08b-aa91266e257b -->","subChapters":[{"id":"cf9787bd-6a46-5398-9707-7f41b18c9eca","slug":"basis-for-recommendation-d5e","fullItemName":"Basis for recommendation","depth":5,"htmlHeader":"<!-- begin field 6636b988-5aca-4607-a17e-8826fa1c87ce --><h5>Basis for recommendation</h5><!-- end field 6636b988-5aca-4607-a17e-8826fa1c87ce -->","summary":null,"htmlStringContent":"<!-- begin item d5e4a853-c23a-416c-b148-c5326819eea8 --><!-- begin field 3723de05-dd72-4a2d-97fa-19095e9d6c0c --><p>These recommendations are based on the British Association for Sexual Health and HIV guideline <em>UK national guideline on the management of vulval condition</em>s [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">BASHH, 2014</a>], the <em>2016 European guideline for the management of vulval conditions</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">van der Meijden, 2017</a>], and expert opinion in a narrative review <em>Recognition and management of vulvar dermatologic conditions: lichen sclerosus, Lichen planus, and lichen simplex chronicus </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">Thorstensen, 2012</a>].</p><h6>Preference for corticosteroid ointment over cream [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">van der Meijden, 2017</a>]</h6><ul><li>Corticosteroid ointments are preferred to creams on the anogenital skin, as they have a reduced need for preservatives, which may cause secondary contact allergy.</li><li>Creams also have more water content than ointments and may sting when applied.</li></ul><!-- end field 3723de05-dd72-4a2d-97fa-19095e9d6c0c --><!-- end item d5e4a853-c23a-416c-b148-c5326819eea8 -->","subChapters":[]}]},{"id":"ead6b178-596b-5826-88a8-455866d2c558","slug":"infections-infestations","fullItemName":"Infections and infestations","depth":4,"htmlHeader":"<!-- begin field d0f9b8fb-44f6-49cc-a5b7-c3ee050185f3 --><h4>How should I manage infections or infestations?</h4><!-- end field d0f9b8fb-44f6-49cc-a5b7-c3ee050185f3 -->","summary":null,"htmlStringContent":"<!-- begin item 357a40b3-8759-476a-9dda-b403a488a4f3 --><!-- begin field cab6da5d-caa9-46dd-839a-a90f31cb9a8a --><ul><li><strong>For information on managing the underlying infection or infestation, </strong>see the CKS topics on:<ul><li><a class=\"topic-reference external-reference\" href=\"/topics/bacterial-vaginosis/\">Bacterial vaginosis</a>.</li><li><a class=\"topic-reference external-reference\" href=\"/topics/candida-female-genital/\">Candida - female genital</a>.</li><li><a class=\"topic-reference external-reference\" href=\"/topics/herpes-simplex-genital/\">Herpes simplex - genital</a>.</li><li><a class=\"topic-reference external-reference\" href=\"/topics/pubic-lice/\">Pubic lice</a>.</li><li><a class=\"topic-reference external-reference\" href=\"/topics/scabies/\">Scabies</a>.</li><li><a class=\"topic-reference external-reference\" href=\"/topics/threadworm/\">Threadworm</a>.</li><li><a class=\"topic-reference external-reference\" href=\"/topics/trichomoniasis/\">Trichomoniasis</a>.</li></ul></li></ul><!-- end field cab6da5d-caa9-46dd-839a-a90f31cb9a8a --><!-- end item 357a40b3-8759-476a-9dda-b403a488a4f3 -->","subChapters":[]},{"id":"1e359df8-4ae0-56cc-a6eb-ca26806be116","slug":"possible-neoplasm","fullItemName":"Possible neoplasm","depth":4,"htmlHeader":"<!-- begin field ee02897f-b9a2-4681-a63c-08bac7714e09 --><h4>How should I manage a possible vulval neoplasm?</h4><!-- end field ee02897f-b9a2-4681-a63c-08bac7714e09 -->","summary":null,"htmlStringContent":"<!-- begin item 029f8940-0bb2-45b5-b3bb-13b8e5f17870 --><!-- begin field bc3ea909-90f4-4ff5-a605-65a9d68a94a9 --><ul><li><strong>Refer urgently (within 2 weeks) all women with: </strong><ul><li>An unexplained vulval lump, ulceration, or bleeding.  <ul><li>Suspect vulval intraepithelial neoplasia (VIN) for any persistent area of abnormality that is thick, warty or ulcerated. </li></ul></li><li>An unexplained palpable mass in, or at the entrance to the vagina.</li></ul></li></ul><!-- end field bc3ea909-90f4-4ff5-a605-65a9d68a94a9 --><!-- end item 029f8940-0bb2-45b5-b3bb-13b8e5f17870 -->","subChapters":[{"id":"5f268e4b-8c83-5b9a-85ff-a5af76a73779","slug":"basis-for-recommendation-bc7","fullItemName":"Basis for recommendation","depth":5,"htmlHeader":"<!-- begin field 992fa254-bbdc-4438-950a-0c37b840291c --><h5>Basis for recommendation</h5><!-- end field 992fa254-bbdc-4438-950a-0c37b840291c -->","summary":null,"htmlStringContent":"<!-- begin item bc79175c-b7b4-45db-be46-d0e7cf301d22 --><!-- begin field 2768805e-4c3b-4576-8aad-579cf587f434 --><p>These recommendations are based on National Institute for Health and Clinical Excellence guidance <em>Suspected cancer: recognition and referral</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">NICE, 2015</a>]<em> </em>and expert opinion in a narrative review <em>Common vulval dermatoses</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">Drummond, 2011</a>].</p><!-- end field 2768805e-4c3b-4576-8aad-579cf587f434 --><!-- end item bc79175c-b7b4-45db-be46-d0e7cf301d22 -->","subChapters":[]}]},{"id":"1e85e490-ac2d-5a01-a13e-f1be14a28d28","slug":"hormonal-changes","fullItemName":"Hormonal changes","depth":4,"htmlHeader":"<!-- begin field 9ba499b1-e492-4572-bd5c-4a680f569882 --><h4>How should I manage hormonal changes which cause pruritus vulvae?</h4><!-- end field 9ba499b1-e492-4572-bd5c-4a680f569882 -->","summary":null,"htmlStringContent":"<!-- begin item 91ff7f45-7c62-44ed-812c-3e98f21de001 --><!-- begin field 366092be-f1dd-4f35-8f9d-76117cb6a3ab --><ul><li><strong>Manage pruritus vulvae appropriately, depending on the underlying cause:</strong><ul><li><strong>Atrophic vaginitis </strong>— see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/menopause/\">Menopause</a>.</li><li><strong>Pregnancy </strong>—<strong> </strong>see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/itch-in-pregnancy/\">Itch in pregnancy</a>.</li></ul></li></ul><!-- end field 366092be-f1dd-4f35-8f9d-76117cb6a3ab --><!-- end item 91ff7f45-7c62-44ed-812c-3e98f21de001 -->","subChapters":[{"id":"8a608965-447b-58cb-be2a-726e205f5407","slug":"basis-for-recommendation-e36","fullItemName":"Basis for recommendation","depth":5,"htmlHeader":"<!-- begin field c9f2f6bc-91c9-4718-bcc0-37dfa4c26abd --><h5>Basis for recommendation</h5><!-- end field c9f2f6bc-91c9-4718-bcc0-37dfa4c26abd -->","summary":null,"htmlStringContent":"<!-- begin item e36f154d-ad1b-4fb0-aad3-aded8d8179e7 --><!-- begin field fbe66c03-9328-402d-9c12-fb02d4c7a732 --><p>The evidence to support the management of hormonal changes is discussed within the relevant CKS topic.</p><!-- end field fbe66c03-9328-402d-9c12-fb02d4c7a732 --><!-- end item e36f154d-ad1b-4fb0-aad3-aded8d8179e7 -->","subChapters":[]}]},{"id":"1c45e434-a808-5573-85b2-0d2ea66b2469","slug":"gastrointestinal-disease-urinary-incontinence","fullItemName":"Gastrointestinal disease and urinary incontinence","depth":4,"htmlHeader":"<!-- begin field 3405baaf-0a22-485c-88a3-6f864efa5b3b --><h4>How should I manage gastrointestinal disease or urinary incontinence which is causing pruritus vulvae?</h4><!-- end field 3405baaf-0a22-485c-88a3-6f864efa5b3b -->","summary":null,"htmlStringContent":"<!-- begin item 40596a1f-ac7b-4ce0-88dd-d1bee0341103 --><!-- begin field 622991b6-493a-4afc-9a5d-aa3af71cf71d --><ul><li><strong>Manage pruritus vulvae appropriately, depending on the underlying cause:</strong><ul><li><strong>Faecal incontinence </strong>—<strong> </strong>manage faecal incontinence (for example regular toileting, use of barrier creams). Refer to a specialist if required. </li><li><strong>Poor perianal hygiene </strong>— provide advice on appropriate hygiene measures.</li><li><strong>Urinary incontinence </strong>— for information on managing urinary incontinence, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/incontinence-urinary-in-women/\">Incontinence - urinary, in women</a>.</li></ul></li></ul><!-- end field 622991b6-493a-4afc-9a5d-aa3af71cf71d --><!-- end item 40596a1f-ac7b-4ce0-88dd-d1bee0341103 -->","subChapters":[{"id":"e1a4d4b2-f287-5471-b042-65fd35e435b2","slug":"basis-for-recommendation-4d6","fullItemName":"Basis for recommendation","depth":5,"htmlHeader":"<!-- begin field 3784e1a7-b13b-4f68-805b-6569ed9c984d --><h5>Basis for recommendation</h5><!-- end field 3784e1a7-b13b-4f68-805b-6569ed9c984d -->","summary":null,"htmlStringContent":"<!-- begin item 4d6d0593-f0fc-4aa1-b38d-a2764ebf6a1e --><!-- begin field 18bf1b0f-32fa-47fe-9abe-f00cec0b4ad0 --><p>These recommendations are based on expert opinion in a narrative review <em>Recognition and management of vulvar dermatologic conditions: lichen sclerosus, lichen planus, and lichen simplex chronicus</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">Thorstensen, 2012</a>], and what CKS considers to be good practice.</p><!-- end field 18bf1b0f-32fa-47fe-9abe-f00cec0b4ad0 --><!-- end item 4d6d0593-f0fc-4aa1-b38d-a2764ebf6a1e -->","subChapters":[]}]},{"id":"bdd58b38-5cae-5ada-8f20-00a41b17460a","slug":"systemic-causes","fullItemName":"Systemic causes","depth":4,"htmlHeader":"<!-- begin field 3dbbe3f8-7b66-406f-8b52-fd36c5298748 --><h4>How should I manage a systemic cause of pruritus vulvae?</h4><!-- end field 3dbbe3f8-7b66-406f-8b52-fd36c5298748 -->","summary":null,"htmlStringContent":"<!-- begin item 8b452455-b17f-4fbf-ade3-503a1dcc2425 --><!-- begin field 788299f7-067c-4dc4-89c0-063b360f61d3 --><ul><li><strong>Manage the underlying cause:</strong><ul><li><strong>Anaemia (iron deficiency) </strong>—  see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/anaemia-iron-deficiency/\">Anaemia - iron deficiency</a>.</li><li><strong>Anaemia (vitamin B<sub>12 </sub>and folate deficiency) </strong>— see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/anaemia-b12-folate-deficiency/\">Anaemia - B12 and folate deficiency</a>. </li><li><strong>Diabetes mellitus </strong>— see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-1/\">Diabetes - type 1</a> and <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-2/\">Diabetes - type 2</a>.</li><li><strong>Hepatic disease</strong> — see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/gallstones/\">Gallstones</a>, <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-a/\">Hepatitis A</a>, <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-b/\">Hepatitis B</a>, <a class=\"topic-reference external-reference\" href=\"/topics/hepatitis-c/\">Hepatitis C</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/jaundice-in-adults/\">Jaundice in adults</a>. </li><li><strong>Hyperthyroidism </strong>— see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/hyperthyroidism/\">Hyperthyroidism</a>.</li><li><strong>Hypothyroidism </strong>— see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/hypothyroidism/\">Hypothyroidism</a>.</li><li><strong>End-stage renal disease</strong> — see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/chronic-kidney-disease/\">Chronic kidney disease</a>.</li><li><strong>Suspected lymphoma</strong> — consider a suspected cancer pathway referral (for an appointment within 2 weeks).</li><li><strong>Psychological problems</strong> — consider referral to a psychiatrist, if appropriate. See the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/depression/\">Depression</a>, <a class=\"topic-reference external-reference\" href=\"/topics/generalized-anxiety-disorder/\">Generalized anxiety disorder</a> and <a class=\"topic-reference external-reference\" href=\"/topics/insomnia/\">Insomnia</a>. </li></ul></li></ul><!-- end field 788299f7-067c-4dc4-89c0-063b360f61d3 --><!-- end item 8b452455-b17f-4fbf-ade3-503a1dcc2425 -->","subChapters":[{"id":"37265e99-1dff-551f-9c9b-318cc0aec9e9","slug":"basis-for-recommendation-de8","fullItemName":"Basis for recommendation","depth":5,"htmlHeader":"<!-- begin field 677481b9-9150-4d32-8a43-772eb972c882 --><h5>Basis for recommendation</h5><!-- end field 677481b9-9150-4d32-8a43-772eb972c882 -->","summary":null,"htmlStringContent":"<!-- begin item de83aba1-1795-42f4-a42f-af33696cdeba --><!-- begin field 7de9fcc3-a63d-4a2e-8d19-eacdd6fbc0c2 --><p>These recommendations are based on the National Institute for Health and Clinical Excellence (NICE) guideline <em>Suspected cancer: recognition and referral </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">NICE, 2015</a>], the British Medical Journal (BMJ) Best Practice guide <em>Assessment of pruritus</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">BMJ, 2017</a>], and what CKS consider good clinical practice. </p><!-- end field 7de9fcc3-a63d-4a2e-8d19-eacdd6fbc0c2 --><!-- end item de83aba1-1795-42f4-a42f-af33696cdeba -->","subChapters":[]}]}]},{"id":"b3da4c4b-e61c-5ea4-b89e-b7347b1c45d0","slug":"unknown-cause","fullItemName":"Unknown cause","depth":3,"htmlHeader":"<!-- begin field be7ad9b8-fd29-4734-8e1d-f0c114e81baa --><h3>How should I manage pruritus vulvae with an unknown cause?</h3><!-- end field be7ad9b8-fd29-4734-8e1d-f0c114e81baa -->","summary":null,"htmlStringContent":"<!-- begin item c3c4b671-21f1-4dd8-8fec-3bc9a8794dba --><!-- begin field dea0fba4-6ae7-4c00-8546-651b87edb70d --><p><strong>The aim of treatment is to provide symptomatic relief, reduce inflammation, restore the skin barrier and prevent and/or treat secondary infection. </strong></p><ul><li>Offer <a class=\"topic-reference internal-reference\" href=\"/topics/pruritus-vulvae/management/management/#symptomatic-treatment\">symptomatic treatment</a> with an emollient and a mildly anxiolytic antihistamine (such as hydroxyzine).</li><li>Consider prescribing a short trial (1-2 weeks) of low potency topical corticosteroids (hydrocortisone 1% ointment).</li><li>Consider prescribing a combination corticosteroid/antifungal, or corticosteroid/antibacterial if a co-existing infection is suspected.</li><li>If symptoms persist despite treatment with an emollient, an antihistamine, and a trial of low potency topical corticosteroids, <a class=\"topic-reference internal-reference\" href=\"/topics/pruritus-vulvae/management/management/#referral\">refer</a> for further investigation to a dermatologist, gynaecologist, or vulval clinic depending on local referral pathways. </li><li>Advise the woman to continue using an emollient and an antihistamine while awaiting specialist appointment.</li></ul><!-- end field dea0fba4-6ae7-4c00-8546-651b87edb70d --><!-- end item c3c4b671-21f1-4dd8-8fec-3bc9a8794dba -->","subChapters":[{"id":"6a6b831f-2df6-57a5-908a-abc01aac0e6c","slug":"basis-for-recommendation-144","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field a599504c-1bfd-410f-a9b5-a24ad21c94c1 --><h4>Basis for recommendation</h4><!-- end field a599504c-1bfd-410f-a9b5-a24ad21c94c1 -->","summary":null,"htmlStringContent":"<!-- begin item 1444f7ae-be70-4a80-b534-ee03fb0caeb9 --><!-- begin field c7c9cd3a-9b37-4ffd-b054-f68b2684d63d --><p>CKS found no guidelines on managing pruritus vulvae where no underlying cause has been identified. These recommendations are based on the British Association for Sexual Health and HIV (BASHH) <em>UK national guideline on the management of vulval condition</em>s [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">BASHH, 2014</a>], and expert opinion in the (BASHH) a narrative review <em>Vulvar dermatoses: a practical approach to evaluation and management</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">Stewart, 2012</a>], and what CKS considers good clinical practice. </p><ul><li>CKS considers that in the absence of a known cause, a general treatment approach should be considered.<ul><li>A general treatment approach, including restoring the skin barrier, reducing inflammation, symptomatic relief, and preventing and treating secondary infection has the potential to address vulvar symptoms caused by eczematous dermatitis, lichen simplex chronicus, and allergic or irritant contact dermatitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">Stewart, 2012</a>].</li><li>This approach also may significantly improve symptoms of lichen sclerosus, lichen planus, and psoriasis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">Stewart, 2012</a>].</li></ul></li><li>Opinion from CKS expert reviewers was divided regarding the use of low potency topical corticosteroids in women who have pruritus vulvae with an unknown cause.</li><li>However, CKS recommends that treatment may be considered on the basis that some women may benefit, and a short trial of low potency corticosteroids is unlikely to cause harm.</li></ul><!-- end field c7c9cd3a-9b37-4ffd-b054-f68b2684d63d --><!-- end item 1444f7ae-be70-4a80-b534-ee03fb0caeb9 -->","subChapters":[]}]},{"id":"c1b7df76-d8a8-5c1a-a669-2f54c49f4de7","slug":"symptomatic-treatment","fullItemName":"Symptomatic treatment","depth":3,"htmlHeader":"<!-- begin field 9c2ec65d-b2fe-4bae-9003-b1e731b725fd --><h3>What symptomatic treatment should I offer a woman with pruritus vulvae?</h3><!-- end field 9c2ec65d-b2fe-4bae-9003-b1e731b725fd -->","summary":null,"htmlStringContent":"<!-- begin item 2134d38f-0cba-4f6f-9c6d-2875d27ebad0 --><!-- begin field 4161db1b-63c4-49b8-9c16-2c0606862220 --><ul><li>For all women with pruritus vulvae, consider prescribing:<ul><li><strong>An emollient </strong>— advise the woman to apply the emollient directly to the vulval area regularly as well as using it as a soap substitute.<ul><li>When used regularly (even when there are no symptoms), an emollient protects the skin against local irritants (for example, urine or menstrual blood) and may help to prevent flare-ups.</li><li>For more information on prescribing emollients, see the section on <a class=\"topic-reference external-reference\" href=\"/topics/eczema-atopic/prescribing-information/emollients/\">Emollients</a> in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/eczema-atopic/\">Eczema - atopic</a>.</li></ul></li><li><strong>A mildly anxiolytic <a class=\"topic-reference internal-reference\" href=\"/topics/pruritus-vulvae/prescribing-information/hydroxyzine/\">antihistamine</a></strong> at night, such as hydroxyzine to reduce nocturnal itching.</li><li>Do not prescribe hydroxyzine if the person has a prolonged QT interval or risk factors for QT interval prolongation. For more information, see the section on prescribing information in the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/itch-widespread/\">Itch - widespread</a>.</li></ul></li></ul><!-- end field 4161db1b-63c4-49b8-9c16-2c0606862220 --><!-- end item 2134d38f-0cba-4f6f-9c6d-2875d27ebad0 -->","subChapters":[{"id":"8b5aad45-3c2b-5962-a1d9-2e927611d797","slug":"basis-for-recommendation-c6a","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 9d5d466a-9e9a-412a-8d02-dfdffaee5f77 --><h4>Basis for recommendation</h4><!-- end field 9d5d466a-9e9a-412a-8d02-dfdffaee5f77 -->","summary":null,"htmlStringContent":"<!-- begin item c6a87f8b-737b-4eda-aa0e-f4a7863cf594 --><!-- begin field 79e7ab9b-cc85-4e1a-811d-c33796e2dda3 --><p>These recommendations are based on the British Association for Sexual Health and HIV (BASHH) <em>UK national guideline on the management of vulval condition</em>s [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">BASHH, 2014</a>], the <em>2016 European guideline for the management of vulval conditions</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">van der Meijden, 2017</a>], and expert opinion in narrative reviews <em>Recognition and management of vulvar dermatologic conditions: lichen sclerosus, lichen planus, and lichen simplex chronicus</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">Thorstensen, 2012</a>] and <em>Vulvar dermatoses: a practical approach to evaluation and management </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">Stewart, 2012</a>]<em>. </em></p><ul><li>The recommendation not to prescribe hydroxyzine if the person has a prolonged QT interval, or risk factors for QT interval prolongation, is based on a Medicines and Healthcare products Regulatory Agency (MHRA) drug safety update [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">MHRA, 2015</a>].</li></ul><!-- end field 79e7ab9b-cc85-4e1a-811d-c33796e2dda3 --><!-- end item c6a87f8b-737b-4eda-aa0e-f4a7863cf594 -->","subChapters":[]}]},{"id":"8510b600-74c7-5bb8-aaf0-601c50283f75","slug":"self-care-advice","fullItemName":"Self-care advice","depth":3,"htmlHeader":"<!-- begin field 1c12f353-b2ac-48f4-a298-7733c2213fb9 --><h3>What self-care advice should I give to women with pruritus vulvae?</h3><!-- end field 1c12f353-b2ac-48f4-a298-7733c2213fb9 -->","summary":null,"htmlStringContent":"<!-- begin item 0940b372-e073-422f-9767-881eafaf59e8 --><!-- begin field 2f451ee5-8b15-42bc-a9f3-f1c291a4dafd --><ul><li><strong>Advise the woman:</strong><ul><li>To shower rather than bath, and to clean the vulval area (a maximum of once a day) with an emollient as a soap substitute — over cleaning may aggravate vulval symptoms. Once the vulval area is clean, gently dab the vulval area dry with a soft towel or use a hairdryer on a cool setting held well away from the skin.</li></ul></li><li><strong>Advise women with pruritus vulvae to avoid:</strong><ul><li>Washing with water only, or with soap, as these cause dry skin and make itching worse.</li><li>Contact of the vulval skin with:<ul><li>Shampoo.</li><li>Bubble bath.</li><li>Over-the-counter preparations used on the vulva.</li><li>Wet wipes (feminine or baby).</li><li>Perfumed sanitary towels and panty liners.</li><li>Sponges or flannels — these may irritate the skin.</li><li>Antiseptics.</li></ul></li><li>Tight-fitting garments or synthetic clothes, for example nylon underwear, as these may irritate the vulval area.</li><li>Fabric conditioner or biological washing powder when washing underwear.</li><li>Use of spermicidally-lubricated condoms.</li><li>Coloured toilet paper.</li><li>Wearing nail varnish on fingernails if they are scratching.</li></ul></li></ul><!-- end field 2f451ee5-8b15-42bc-a9f3-f1c291a4dafd --><!-- end item 0940b372-e073-422f-9767-881eafaf59e8 -->","subChapters":[{"id":"0f049584-c300-54cd-a828-f701fca352a1","slug":"basis-for-recommendation-67c","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 2b9cc68e-5f6f-461c-9d69-250cd3baa413 --><h4>Basis for recommendation</h4><!-- end field 2b9cc68e-5f6f-461c-9d69-250cd3baa413 -->","summary":null,"htmlStringContent":"<!-- begin item 67cac236-2735-4d77-a721-5bb7279d4f88 --><!-- begin field 75fee1b5-77eb-4029-b6d3-238406d763a0 --><p>These recommendations are based on the British Association for Sexual Health and HIV (BASHH) <em>UK national guideline on the management of vulval condition</em>s [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">BASHH, 2014</a>], the Royal College of Obstetricians and Gynaecologists <em>Guidelines for the diagnosis and management of vulval carcinoma </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">RCOG, 2014</a>], the <em>2016 European guideline for the management of vulval conditions </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">van der Meijden, 2017</a>]<em>,</em> expert opinion in narrative reviews <em>Overview of vulvar pruritus through the life cycle</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">Bohl, 2005</a>], and <em>Itchy vulva </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">DNNZ, 2016a</a>]<em>, </em>and<em> </em>patient information leaflets <em>Care of vulval skin</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">BAD, 2016</a>], and <em>Skin conditions of the vulva</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">RCOG, 2013</a>].</p><h5>Self examination</h5><ul><li>The Vulval Pain Society recommends vulval self examination, however there is no evidence to show that this is beneficial [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">RCOG, 2014</a>].</li></ul><!-- end field 75fee1b5-77eb-4029-b6d3-238406d763a0 --><!-- end item 67cac236-2735-4d77-a721-5bb7279d4f88 -->","subChapters":[]}]},{"id":"9a1f97ce-10f5-5e0b-8fef-644b8fe0d963","slug":"referral","fullItemName":"Referral","depth":3,"htmlHeader":"<!-- begin field 49087948-b506-45fd-b660-06be51610476 --><h3>When should I refer a woman with pruritus vulvae?</h3><!-- end field 49087948-b506-45fd-b660-06be51610476 -->","summary":null,"htmlStringContent":"<!-- begin item 85d14670-3a7e-45b0-a1eb-ec580143d083 --><!-- begin field 0d80b9b6-b618-42af-9340-a364b792c66b --><ul><li><strong>Referral to a dermatologist or gynaecologist with expertise in managing vulval disease </strong>is indicated if:<ul><li>The cause of the pruritus vulvae is unclear and symptoms persist.<ul><li>The urgency of the referral will depend on the nature of the symptoms and degree of concern (if any) about cancer.</li></ul></li><li>The cause is known, but symptoms persist despite primary care management:<ul><li>For example, some women with contact dermatitis may require referral to try and identify the irritant or allergen. If allergic contact dermatitis is suspected, then patch test investigations may be initiated.</li></ul></li><li>A premalignant condition, such as vulval intraepithelial neoplasia, lichen sclerosus, or lichen planus, is suspected.</li></ul></li><li><strong>Urgent referral (within 2 weeks) </strong>is indicated if:<ul><li>Vulval carcinoma is suspected (for example if the woman has an unexplained vulval lump or ulcer).</li><li>Lymphoma is suspected. </li></ul></li><li>Also consider referral to the appropriate specialist if the underlying cause of pruritus vulvae is <a class=\"topic-reference internal-reference\" href=\"/topics/pruritus-vulvae/management/management/#systemic-causes\">systemic</a> disease.</li></ul><!-- end field 0d80b9b6-b618-42af-9340-a364b792c66b --><!-- end item 85d14670-3a7e-45b0-a1eb-ec580143d083 -->","subChapters":[{"id":"fda4f155-870d-5a6a-bfbf-a3249f7206d4","slug":"basis-for-recommendation-b5b","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 66ffd2f5-4b02-48be-be1b-4cd2e7956fac --><h4>Basis for recommendation</h4><!-- end field 66ffd2f5-4b02-48be-be1b-4cd2e7956fac -->","summary":null,"htmlStringContent":"<!-- begin item b5b94da0-3365-488c-b887-453f79c79e14 --><!-- begin field a7b80fc0-186b-44c0-9ac1-bd5b701d2d5d --><p>These recommendations are based on the British Association for Sexual Health and HIV (BASHH) <em>UK national guideline on the management of vulval condition</em>s [<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">BASHH, 2014</a>], the National Institute for Health and Clinical Excellence (NICE) guideline <em>Suspected cancer: recognition and referral </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">NICE, 2015</a>] and the <em>2016 European guideline for the management of vulval conditions </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/pruritus-vulvae/references/\">van der Meijden, 2017</a>]<em>.</em></p><!-- end field a7b80fc0-186b-44c0-9ac1-bd5b701d2d5d --><!-- end item b5b94da0-3365-488c-b887-453f79c79e14 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}